Multiply Labs envisions a world where every patient has access to next-gen, precision medicines.
To illustrate that vision through design, we materialized Multiply Labs robotic technology into the ROBOTIC CELL THERAPY CLUSTER: a robotic system to manufacture precision capsular dosage medicines.
Controlled by cloud-based software, the beauty of the cluster lies in how it all works together, automating the cell therapy production process from end to end.
Smooth interactions and visible processes were prioritized so that operators and clients alike could easily understand the underlying concept by just looking at the design.
Multiply Labs ROBOTIC CELL THERAPY CLUSTER is the first robotic system able to manufacture precision capsular dosage forms on an industrial scale. It combines innovative technology with a highly modular system capable of reducing manufacturing bottlenecks and minimizing human contamination thanks to a series of automations.
To express system modularity and robotic automation through industrial design, the clusters were designed to be:
Compatible with the market-leading GMP instruments.
Flexible: select the combination of modules that matches your process.
High throughput: by using multiple modules in parallel.
Parallel production: allowing the production of different medications at the same time and without the need to reset the production line.
Higher sterility: less risk for human contamination
Category:MedicalYear:2023Designer:Pasquale Cirulli, Jesus Vega, Gabriel Zangari, Matteo Smorgon, Design Group Italia, New York, New York, USAManufacturer:Multiply Labs Inc., San Francisco, California, USA